| 标题 |
 Real-World Treatment Patterns and Costs of Chimeric Antigen Receptor (CAR) T Cell Therapies, Polatuzumab Vedotin-Piiq (Pola), and Tafasitamab-Cxix (Tafa) in Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) |
| 网址 | |
| DOI |
10.1182/blood-2022-162587
doi
|
| 其它 |
期刊：Blood 作者：Fei Fei Liu; Krishnaveni Subbiah; Tao Gu; Trong Kim Le 出版日期：2022-11-15 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的冬萱
Kao
Copyright
cdercder
潇洒的惋清
OK
舒适的如萱
MozzieMiao
Nole
天晴
arniu2008
liuzhuohao
Nexus
嘉心糖
科研狗
殷勤的紫槐
lieaait
Oracle
卡乐瑞咩吹可
Avalonx
皖公网安备34019202002308
